Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 3 |
2022 | 5 |
2023 | 3 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Targeting Potential of Innate Lymphoid Cells in Melanoma and Other Cancers.
Pharmaceutics. 2023 Jul 21;15(7):2001. doi: 10.3390/pharmaceutics15072001.
Pharmaceutics. 2023.
PMID: 37514187
Free PMC article.
Review.
Rituximab Toxicity after Preemptive or Therapeutic Administration for Post-Transplant Lymphoproliferative Disorder.
Kinzel M, Kalra A, Khanolkar RA, Williamson TS, Li N, Khan F, Puckrin R, Duggan PR, Shafey M, Storek J.
Kinzel M, et al.
Transplant Cell Ther. 2023 Jan;29(1):43.e1-43.e8. doi: 10.1016/j.jtct.2022.10.013. Epub 2022 Oct 20.
Transplant Cell Ther. 2023.
PMID: 36273783
Free article.
Item in Clipboard
A biomarker-guided, prospective, phase 2 trial of pre-emptive graft-versus-host disease therapy using anti-thymocyte globulin.
Khanolkar RA, Kalra A, Kinzel M, Pratt LM, Dharmani-Khan P, Chaudhry A, Williamson TS, Daly A, Morris DG, Khan FM, Storek J.
Khanolkar RA, et al. Among authors: kinzel m.
Cytotherapy. 2021 Nov;23(11):1007-1016. doi: 10.1016/j.jcyt.2021.06.003. Epub 2021 Aug 6.
Cytotherapy. 2021.
PMID: 34373186
Clinical Trial.
Item in Clipboard
Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation.
Kinzel M, Dowhan M, Kalra A, Williamson TS, Dabas R, Jamani K, Chaudhry A, Shafey M, Jimenez-Zepeda V, Duggan P, Daly A, Dharmani-Khan P, Khan F, Storek J.
Kinzel M, et al.
Transplant Cell Ther. 2022 Jan;28(1):53.e1-53.e10. doi: 10.1016/j.jtct.2021.09.021. Epub 2021 Oct 1.
Transplant Cell Ther. 2022.
PMID: 34607072
Free article.
Item in Clipboard
Impact of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation.
Khanolkar RA, Faridi RM, Kinzel M, Jamani K, Savoie ML, Shafey M, Khan FM, Storek J.
Khanolkar RA, et al. Among authors: kinzel m.
Cytotherapy. 2022 Apr;24(4):413-420. doi: 10.1016/j.jcyt.2021.10.006. Epub 2021 Dec 2.
Cytotherapy. 2022.
PMID: 34863627
Item in Clipboard
Lack of both donor and recipient anti-EBV T cells in EBV seronegative recipients of grafts from seropositive donors.
Kinzel M, Kalra A, Tripathi G, Dharmani-Khan P, Khan F, Storek J.
Kinzel M, et al.
Bone Marrow Transplant. 2023 Mar;58(3):332-333. doi: 10.1038/s41409-022-01884-3. Epub 2022 Nov 30.
Bone Marrow Transplant. 2023.
PMID: 36450829
No abstract available.
Item in Clipboard
Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease.
Khanolkar RA, Tripathi G, Dharmani-Khan P, Dabas R, Kinzel M, Kalra A, Puckrin R, Jimenez-Zepeda V, Jamani K, Duggan PR, Chaudhry A, Bryant A, Stewart DA, Khan FM, Storek J.
Khanolkar RA, et al. Among authors: kinzel m.
Cytotherapy. 2022 Dec;24(12):1225-1231. doi: 10.1016/j.jcyt.2022.07.013. Epub 2022 Sep 1.
Cytotherapy. 2022.
PMID: 36057497
Item in Clipboard
Cite
Cite